• Biohaven Announces Formation of Bioshin americanpharmaceuticalreview
    November 30, 2018
    Biohaven has advanced the formation of a wholly owned subsidiary, BioShin, a Shanghai based limited liability company, to develop and commercialize its late-stage migraine....
PharmaSources Customer Service